[Righetti72] Fwd: Fw: all drugs have a generic name

Debra Wallace djwallace@sbcglobal.net
Sun, 1 Jun 2003 09:50:38 -0700 (PDT)


--0-1805477779-1054486238=:50738
Content-Type: multipart/alternative; boundary="0-1849125926-1054486238=:50738"

--0-1849125926-1054486238=:50738
Content-Type: text/plain; charset=us-ascii



Note: forwarded message attached.

--0-1849125926-1054486238=:50738
Content-Type: text/html; charset=us-ascii

<DIV><BR><BR>Note: forwarded message attached.</DIV>
--0-1849125926-1054486238=:50738--
--0-1805477779-1054486238=:50738
Content-Type: message/rfc822

X-Apparently-To: djwallace@sbcglobal.net via web80001.mail.yahoo.com; 20 May 2003 09:57:28 -0700 (PDT)
Return-Path: <emraborg@cox.net>
Received: from vmb-ext.prodigy.net (207.115.63.87)
  by mta802.mail.yahoo.com with SMTP; 20 May 2003 09:57:28 -0700 (PDT)
X-Originating-IP: [68.1.17.114]
Received: from lakemtao07.cox.net (lakemtao07.cox.net [68.1.17.114])
	by vmb-ext.prodigy.net (8.12.9/8.12.3) with ESMTP id h4KGvEhe623070
	for <djwallace@sbcglobal.net>; Tue, 20 May 2003 12:57:27 -0400
Received: from ilenen81ja6n9o ([68.12.42.55]) by lakemtao07.cox.net
          (InterMail vM.5.01.04.05 201-253-122-122-105-20011231) with SMTP
          id <20030520165702.GEKA4514.lakemtao07.cox.net@ilenen81ja6n9o>;
          Tue, 20 May 2003 12:57:02 -0400
From: "Eileen Raborg" <emraborg@cox.net>
To: "Becky Price" <woowoobeckyboo@yahoo.com>,
   "Debra Wallace" <djwallace@sbcglobal.net>,
   "Patricia A. Bradshaw" <patbradshaw1@juno.com>,
   "Kevin Raborg" <kraborg@cox.net>, "Jayne A. Lane" <Colorqueen1963@aol.com>,
   "Jeff & Brenda Kane" <kane4calib@earthlink.net>,
   "Estelle Wolf" <justgrass@cs.com>
Subject: Fw: all drugs have a generic name
Date: Tue, 20 May 2003 11:57:17 -0500
MIME-Version: 1.0
Content-Type: multipart/related;
	type="multipart/alternative";
	boundary="----=_NextPart_000_003D_01C31EC6.F5B518B0"
X-Priority: 3
X-MSMail-Priority: Normal
X-Mailer: Microsoft Outlook Express 6.00.2800.1158
X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2800.1165
Content-Length: 2917

This is a multi-part message in MIME format.

------=_NextPart_000_003D_01C31EC6.F5B518B0
Content-Type: multipart/alternative;
	boundary="----=_NextPart_001_003E_01C31EC6.F5B518B0"


------=_NextPart_001_003E_01C31EC6.F5B518B0
Content-Type: text/plain;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable


----- Original Message -----=20
From: Wayne Bradshaw=20
To: Eileen Raborg=20
Sent: Tuesday, May 20, 2003 2:52 AM
Subject: Fw: all drugs have a generic name



-----Original Message-----
From: Rippeeah <rippeeah@ocsnet.net>
To: Jim Chatterton <chatteji@hotmail.com>; pwayne@inreach.com =
<pwayne@inreach.com>; Mary Rippee <ripplee@machspeed.net>
Date: Tuesday, May 20, 2003 6:45 AM
Subject: Fw: all drugs have a generic name




      -------Original Message-------

      From: Gene and Sheila Smith
      Date: Wednesday, May 14, 2003 16:49:17
      To: Smith Floyd & Carol; Rippee, Art; Reyes, Joe; Doan Tom
      Subject: Fw: all drugs have a generic name




      In pharmacology, all drugs have a generic name:
      Tylenol is acetaminophen,
      Aleve is naproxen,
      Amoxil is amoxicillin,
      Advil is ibuprofen, and so on.
      > >>>>
      The FDA has been looking for a generic name for
      Viagra, and announced that it has settled on
      mycoxafloppin. Also considered were mycoxafailin,
      mydixadrupin, mydixarizin, mydixadud, dixafix, and of
      course, ibepokin.=20


    =20
            =20
    =20
____________________________________________________
  IncrediMail - Email has finally evolved - Click Here 
------=_NextPart_001_003E_01C31EC6.F5B518B0
Content-Type: text/html;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD>
<META http-equiv=3DContent-Type =
content=3Dtext/html;charset=3Diso-8859-1>
<META content=3D"MSHTML 6.00.2800.1170" name=3DGENERATOR>
<STYLE></STYLE>
<!--IncrdiXMLRemarkStart>=0D<IncrdiX-Info>=0D<X-FID>FLAVOR00-NONE-0000-00=
00-000000000000</X-FID>=0D<X-FVER></X-FVER>=0D<X-CNT>;</X-CNT>=0D</Incrdi=
X-Info>=0D<IncrdiXMLRemarkEnd--></HEAD>
<BODY style=3D"BACKGROUND-POSITION: 0px 0px; FONT-SIZE: 12pt; =
FONT-FAMILY: "=20
bgColor=3D#ffffff background=3D"" ORGYPOS=3D"0" X-FVER=3D"3.0">
<DIV>&nbsp;</DIV>
<DIV style=3D"FONT: 10pt arial">----- Original Message -----=20
<DIV style=3D"BACKGROUND: #e4e4e4; font-color: black"><B>From:</B> <A=20
title=3Dpwayne@inreach.com href=3D"mailto:pwayne@inreach.com">Wayne =
Bradshaw</A>=20
</DIV>
<DIV><B>To:</B> <A title=3Demraborg@cox.net =
href=3D"mailto:emraborg@cox.net">Eileen=20
Raborg</A> </DIV>
<DIV><B>Sent:</B> Tuesday, May 20, 2003 2:52 AM</DIV>
<DIV><B>Subject:</B> Fw: all drugs have a generic name</DIV></DIV>
<DIV><BR></DIV>
<DIV>&nbsp;</DIV>
<DIV><FONT face=3DArial size=3D2><B>-----Original =
Message-----</B><BR><B>From:=20
</B>Rippeeah &lt;<A=20
href=3D"mailto:rippeeah@ocsnet.net">rippeeah@ocsnet.net</A>&gt;<BR><B>To:=
 </B>Jim=20
Chatterton &lt;<A=20
href=3D"mailto:chatteji@hotmail.com">chatteji@hotmail.com</A>&gt;; <A=20
href=3D"mailto:pwayne@inreach.com">pwayne@inreach.com</A> &lt;<A=20
href=3D"mailto:pwayne@inreach.com">pwayne@inreach.com</A>&gt;; Mary =
Rippee &lt;<A=20
href=3D"mailto:ripplee@machspeed.net">ripplee@machspeed.net</A>&gt;<BR><B=
>Date:=20
</B>Tuesday, May 20, 2003 6:45 AM<BR><B>Subject: </B>Fw: all drugs have =
a=20
generic name<BR><BR></DIV></FONT>
<TABLE id=3DINCREDIMAINTABLE cellSpacing=3D0 cellPadding=3D2 =
width=3D"100%" border=3D0>
  <TBODY>
  <TR>
    <TD id=3DINCREDITEXTREGION=20
    style=3D"FONT-SIZE: 12pt; CURSOR: auto; FONT-FAMILY: Arial" =
width=3D"100%">
      <DIV>&nbsp;</DIV>
      <DIV>&nbsp;</DIV>
      <DIV id=3DIncrediOriginalMessage><I>-------Original =
Message-------</I></DIV>
      <DIV>&nbsp;</DIV>
      <DIV id=3Dreceivestrings>
      <DIV dir=3Dltr style=3D"FONT-SIZE: 11pt" <i><B>From:</B></I> <A=20
      href=3D"mailto:car545@theriver.com">Gene and Sheila =
Smith</A></DIV>
      <DIV dir=3Dltr style=3D"FONT-SIZE: 11pt" <i><B>Date:</B></I> =
Wednesday, May=20
      14, 2003 16:49:17</DIV>
      <DIV dir=3Dltr style=3D"FONT-SIZE: 11pt" <i><B>To:</B></I> <A=20
      href=3D"mailto:floydandcarol@mycidco.com">Smith Floyd &amp; =
Carol</A>; <A=20
      href=3D"mailto:rippeeah@ocsnet.net">Rippee, Art</A>; <A=20
      href=3D"mailto:Grampsreyes@cs.com">Reyes, Joe</A>; <A=20
      href=3D"mailto:dhiplainsdrifter@yahoo.com">Doan Tom</A></DIV>
      <DIV dir=3Dltr style=3D"FONT-SIZE: 11pt" <i><B>Subject:</B></I> =
Fw: all drugs=20
      have a generic name</DIV></DIV>
      <DIV>&nbsp;</DIV>
      <DIV>&nbsp;</DIV>
      <DIV><BR></DIV>In pharmacology, all drugs have a generic =
name:<BR>Tylenol=20
      is acetaminophen,<BR>Aleve is naproxen,<BR>Amoxil is =
amoxicillin,<BR>Advil=20
      is ibuprofen, and so on.<BR>&gt; &gt;&gt;&gt;&gt;<BR>The FDA has =
been=20
      looking for a generic name for<BR>Viagra, and announced that it =
has=20
      settled on<BR>mycoxafloppin. Also considered were=20
      mycoxafailin,<BR>mydixadrupin, mydixarizin, mydixadud, dixafix, =
and=20
      of<BR>course, ibepokin. <BR><BR>
      <DIV>&nbsp;</DIV></TD></TR>
  <TR>
    <TD id=3DINCREDIFOOTER width=3D"100%">
      <TABLE cellSpacing=3D0 cellPadding=3D0 width=3D"100%">
        <TBODY>
        <TR>
          <TD width=3D"100%"></TD>
          <TD id=3DINCREDISOUND vAlign=3Dbottom align=3Dmiddle></TD>
          <TD id=3DINCREDIANIM vAlign=3Dbottom=20
  =
align=3Dmiddle></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE><SPAN =

id=3DIncrediStamp><SPAN dir=3Dltr><FONT face=3D"Arial, Helvetica, =
sans-serif"=20
size=3D2>____________________________________________________<BR><FONT=20
face=3D"Comic Sans MS" size=3D2><A=20
href=3D"http://www.incredimail.com/redir.asp?ad_id=3D309&amp;lang=3D9"><I=
MG alt=3D""=20
hspace=3D0 src=3D"cid:003b01c31ef0$de868cd0$372a0c44@ilenen81ja6n9o" =
align=3Dbaseline=20
border=3D0></A>&nbsp; <I>IncrediMail</I> - <B>Email has finally =
evolved</B> -=20
</FONT><A =
href=3D"http://www.incredimail.com/redir.asp?ad_id=3D309&amp;lang=3D9"><F=
ONT=20
face=3D"Times New Roman" size=3D3><B><U>Click=20
Here</U></B></FONT></A></SPAN></SPAN></FONT> </BODY></HTML>

------=_NextPart_001_003E_01C31EC6.F5B518B0--

------=_NextPart_000_003D_01C31EC6.F5B518B0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-ID: <003b01c31ef0$de868cd0$372a0c44@ilenen81ja6n9o>
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------=_NextPart_000_003D_01C31EC6.F5B518B0--


--0-1805477779-1054486238=:50738--